Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

1,016 results
  1. ... Search term GeneReviews Advanced Search Help < Prev Next > Tyrosine Hydroxylase Deficiency Yoshiaki Furukawa , MD, PhD and Stephen ... Estimated reading time: 28 minutes Summary Clinical characteristics. Tyrosine hydroxylase (TH) deficiency is associated with a broad ...
  2. ... others. Learn more about the gene associated with Tyrosine hydroxylase deficiency TH Inheritance This condition is inherited ...
  3. ... discomfort from a massive spleen. Targeted therapy with tyrosine kinase inhibitors Abbreviations used in this section for ... will be required before these controversies are resolved. Tyrosine kinase inhibitor-resistant CML For patients resistant to ...
  4. ... endothelial growth factor-targeted; VEGF-targeted; VEGFR-targeted; Tyrosine kinase inhibitor-targeted; TKI-targeted; Personalized medicine - cancer
  5. ... tyrosine hydroxylase deficiency. More About This Health Condition Tyrosine hydroxylase deficiency Many variants in the TH gene have been identified in people with tyrosine hydroxylase deficiency. This is a condition that primarily ...
  6. ... deaths (2.2%) were attributed to this complication. Tyrosine kinase inhibitor therapy Lapatinib is an orally administered tyrosine kinase inhibitor of both HER2/neu and the ...
  7. ... spectroscopy, is pathognomonic for tyrosinemia type 1. Elevated tyrosine or methionine concentration in the blood suggests liver ... ordering urine organic acids. Elevated plasma concentration of tyrosine, methionine, and phenylalanine Note: (1) Plasma tyrosine concentration ...
  8. ... and dividing. Cetuximab and necitumumab are EGFR inhibitors. Tyrosine kinase inhibitors Tyrosine kinase inhibitors are small-molecule drugs that go ... cancer cells need to grow and divide. Some tyrosine kinase inhibitors also have angiogenesis inhibitor effects. There ...
  9. ... concurrently with H3.3 mutations.[ 6 - 9 ] Receptor tyrosine kinase amplification: PDGFRA amplification occurs in approximately 30% ... rates of amplification observed for some other receptor tyrosine kinase genes (e.g., MET and IGF1R ).[ 13 , ...
  10. ... disease could not be treated successfully with other tyrosine kinase inhibitor therapies or who cannot take these ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last